These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 6173348)

  • 1. Reversal by hypotonic medium of the antiviral state induced by lymphoblastoid interferon in human HeLa cells.
    Muñoz A; Carrasco L
    Intervirology; 1981; 16(2):106-13. PubMed ID: 6173348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein synthesis and membrane integrity in interferon-treated HeLa cells infected with encephalomyocarditis virus.
    Muñoz A; Carrasco L
    J Gen Virol; 1981 Sep; 56(Pt 1):153-62. PubMed ID: 6170728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversion by hypotonic medium of the shutoff of protein synthesis induced by encephalomyocarditis virus.
    Alonso MA; Carrasco L
    J Virol; 1981 Feb; 37(2):535-40. PubMed ID: 6261005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of murine leukaemia virus production by ouabain and interferon in mouse cells.
    Tomita Y; Kuwata T
    J Gen Virol; 1978 Feb; 38(2):223-30. PubMed ID: 75244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Y2, the smallest of the Sendai virus C proteins, is fully capable of both counteracting the antiviral action of interferons and inhibiting viral RNA synthesis.
    Kato A; Ohnishi Y; Kohase M; Saito S; Tashiro M; Nagai Y
    J Virol; 2001 Apr; 75(8):3802-10. PubMed ID: 11264369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High resistance of human parainfluenza type 2 virus protein-expressing cells to the antiviral and anti-cell proliferative activities of alpha/beta interferons: cysteine-rich V-specific domain is required for high resistance to the interferons.
    Nishio M; Tsurudome M; Ito M; Kawano M; Komada H; Ito Y
    J Virol; 2001 Oct; 75(19):9165-76. PubMed ID: 11533180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formation of non-infective herpesvirus particles in cultured cells treated with human interferon.
    Muñoz A; Carrasco L
    J Gen Virol; 1984 Jun; 65 ( Pt 6)():1069-78. PubMed ID: 6327892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of transcription of herpes simplex virus immediate early genes in interferon-treated human cells.
    Oberman F; Panet A
    J Gen Virol; 1988 Jun; 69 ( Pt 6)():1167-77. PubMed ID: 2455018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variant HeLa cells selected for their resistance to ouabain.
    Rosenberg HM
    J Cell Physiol; 1975 Feb; 85(1):135-42. PubMed ID: 1110260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The comparative anti-herpes simplex virus effects of human interferons.
    Taylor JL; Little SD; O'Brien WJ
    J Interferon Cytokine Res; 1998 Mar; 18(3):159-65. PubMed ID: 9555977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of antiviral activity of spotted souslik (Spermophilus suslicus) interferons.
    Kandefer-Szerszeń M
    Arch Immunol Ther Exp (Warsz); 1987; 35(4):489-99. PubMed ID: 2449874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral Effect of Interferon Lambda Against Lymphocytic Choriomeningitis Virus.
    Lukacikova L; Oveckova I; Betakova T; Laposova K; Polcicova K; Pastorekova S; Pastorek J; Tomaskova J
    J Interferon Cytokine Res; 2015 Jul; 35(7):540-53. PubMed ID: 25830339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Species specificity of interferon action: maintenance and establishment of the antiviral state in the presence of a heterospecific nucleus.
    Veomett MJ; Veomett GE
    J Virol; 1979 Sep; 31(3):785-94. PubMed ID: 513194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type I and type II interferons: differential antiviral actions in transformed cells.
    Bourgeade MF; Chany C; Merigan TC
    J Gen Virol; 1980 Feb; 46(2):449-54. PubMed ID: 6155431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressive effects of interferon on cell fusion by Sendai virus.
    Tomita Y; Kuwata T
    J Gen Virol; 1981 Aug; 55(Pt 2):289-95. PubMed ID: 6169794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour necrosis factor-alpha, interferon-gamma and interferon-beta exert antiviral activity in nervous tissue cells.
    Schijns VE; Van der Neut R; Haagmans BL; Bar DR; Schellekens H; Horzinek MC
    J Gen Virol; 1991 Apr; 72 ( Pt 4)():809-15. PubMed ID: 1849968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral potential of interferon-omega on hepatitis B virus replication in human hepatoma cells.
    Hagelstein J; Kist A; Stremmel W; Galle PR
    Arzneimittelforschung; 1998 Mar; 48(3):343-7. PubMed ID: 9553691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antiviral activity of tumor necrosis factor in HeLa cells is not mediated by interferons. Studies with TNF-resistant variants.
    Gessani S; Johnson SE; McCandless S; Baglioni C
    J Biol Regul Homeost Agents; 1988; 2(3):139-44. PubMed ID: 2474237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variability of interferon-λ induction and antiviral activity in Nipah virus infected differentiated human bronchial epithelial cells of two human donors.
    Sauerhering L; Müller H; Behner L; Elvert M; Fehling SK; Strecker T; Maisner A
    J Gen Virol; 2017 Oct; 98(10):2447-2453. PubMed ID: 28984239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral activity of prostaglandin A on encephalomyocarditis virus-infected cells: a unique effect unrelated to interferon.
    Ankel H; Mittnacht S; Jacobsen H
    J Gen Virol; 1985 Nov; 66 ( Pt 11)():2355-64. PubMed ID: 2414395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.